ELISAs are a benchmark technology that uses a solid-phase enzyme immunoassay to detect the presence of a ligand in a liquid sample using antibodies directed against the protein to be measured.
ELISAs are useful when measuring a limited set of biomarkers and are often combined with cellular assays such as ELISpot or flow cytometry assays.
ELISAs are a component of CellCarta’s full range of clinical biomarker services.
Leveraging the extensive experience of our scientific team, CellCarta optimizes and validates ELISAs for program-specific preclinical and clinical applications.
Whether exploratory, GCLP, or CLIA, our team will meet the most demanding assay challenges.